Global Albendazole

Albendazole Comprehensive Study by Type (Capsule, Tablet), Application (Flatworms, Nematodes, Giardiasis, Microsporidiosis, Granulomatous Amoebic Encephalitis, Arthropods, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online, Others), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2027

Albendazole Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Albendazole Market?

Albendazole is an anti-worm or anthelmintic medication. It is used to prevent newly hatched insect larvae (worms) from growing or multiplying in the human body. Albendazole is used to treat certain infections caused by worms such as dog tapeworm and pork tapeworm. Albendazole is also used along with surgery to treat cystic hydatid disease, this has led to significant growth of the global albendazole market in the forecast period.

The market study is being classified by Type (Capsule and Tablet), by Application (Flatworms, Nematodes, Giardiasis, Microsporidiosis, Granulomatous Amoebic Encephalitis, Arthropods and Others) and major geographies with country level break-up.

Pfizer (United States), Bayer AG (Germany), Merck & Co., Inc. (United States), Provet (Switzerland), Virbac (India), Cipla (India), Novartis AG (Switzerland), CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (United States) and Arsanis, Inc. (Austria) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Novabiotics (United Kingdom), GlaxoSmithKline plc. (United Kingdom), Teva Pharmaceutical Industries Ltd (Taiwan) and Lupin Limited (India).

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European and Asian Players will contribute to the maximum growth of Global Albendazole market throughout the predicted period.

Segment Analysis
Analyst at AMA have segmented the market study of Global Albendazole market by Type, Application and Region.

On the basis of geography, the market of Albendazole has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Incidence of Clonorchis Infections in Asia Pacific Region
  • Increased Number of Diagnostic Centres

Market Trend
  • Technological Advancements in Medical Science
  • Increased Number of Online Pharmacies

Restraints
  • Stringent Government Rules and Regulations

Opportunities
  • Development in Healthcare Infrastructure in Developing Regions

Challenges
  • Various Side Effects like Headache, Neck Stiffness, Increased Sensitivity to Light, Confusion, Fever, and Many Others


On 11th June 2020, Lupin Limited has announced that it has received approval for its Albendazole Tablets USP, 200 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Albenza® Tablets, 200 mg, of Impax Laboratories Inc.


Key Target Audience
Albendazole Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others

Report Objectives / Segmentation Covered

By Type
  • Capsule
  • Tablet
By Application
  • Flatworms
  • Nematodes
  • Giardiasis
  • Microsporidiosis
  • Granulomatous Amoebic Encephalitis
  • Arthropods
  • Others
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online
  • Others

By End User
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Clonorchis Infections in Asia Pacific Region
      • 3.2.2. Increased Number of Diagnostic Centres
    • 3.3. Market Challenges
      • 3.3.1. Various Side Effects like Headache, Neck Stiffness, Increased Sensitivity to Light, Confusion, Fever, and Many Others
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Medical Science
      • 3.4.2. Increased Number of Online Pharmacies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Albendazole, by Type, Application, Distribution Channel, End User and Region (value, volume and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Albendazole (Value)
      • 5.2.1. Global Albendazole by: Type (Value)
        • 5.2.1.1. Capsule
        • 5.2.1.2. Tablet
      • 5.2.2. Global Albendazole by: Application (Value)
        • 5.2.2.1. Flatworms
        • 5.2.2.2. Nematodes
        • 5.2.2.3. Giardiasis
        • 5.2.2.4. Microsporidiosis
        • 5.2.2.5. Granulomatous Amoebic Encephalitis
        • 5.2.2.6. Arthropods
        • 5.2.2.7. Others
      • 5.2.3. Global Albendazole by: Distribution Channel (Value)
        • 5.2.3.1. Hospital Pharmacy
        • 5.2.3.2. Retail Pharmacy
        • 5.2.3.3. Online
        • 5.2.3.4. Others
      • 5.2.4. Global Albendazole by: End User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Clinics
        • 5.2.4.3. Others
      • 5.2.5. Global Albendazole Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Albendazole (Volume)
      • 5.3.1. Global Albendazole by: Type (Volume)
        • 5.3.1.1. Capsule
        • 5.3.1.2. Tablet
      • 5.3.2. Global Albendazole by: Application (Volume)
        • 5.3.2.1. Flatworms
        • 5.3.2.2. Nematodes
        • 5.3.2.3. Giardiasis
        • 5.3.2.4. Microsporidiosis
        • 5.3.2.5. Granulomatous Amoebic Encephalitis
        • 5.3.2.6. Arthropods
        • 5.3.2.7. Others
      • 5.3.3. Global Albendazole by: Distribution Channel (Volume)
        • 5.3.3.1. Hospital Pharmacy
        • 5.3.3.2. Retail Pharmacy
        • 5.3.3.3. Online
        • 5.3.3.4. Others
      • 5.3.4. Global Albendazole by: End User (Volume)
        • 5.3.4.1. Hospitals
        • 5.3.4.2. Clinics
        • 5.3.4.3. Others
      • 5.3.5. Global Albendazole Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Albendazole (Price)
      • 5.4.1. Global Albendazole by: Type (Price)
  • 6. Albendazole: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck & Co., Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Provet (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Virbac (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cipla (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novartis AG (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abbott (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Arsanis, Inc. (Austria)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Albendazole Sale, by Type, Application, Distribution Channel, End User and Region (value, volume and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Albendazole (Value)
      • 7.2.1. Global Albendazole by: Type (Value)
        • 7.2.1.1. Capsule
        • 7.2.1.2. Tablet
      • 7.2.2. Global Albendazole by: Application (Value)
        • 7.2.2.1. Flatworms
        • 7.2.2.2. Nematodes
        • 7.2.2.3. Giardiasis
        • 7.2.2.4. Microsporidiosis
        • 7.2.2.5. Granulomatous Amoebic Encephalitis
        • 7.2.2.6. Arthropods
        • 7.2.2.7. Others
      • 7.2.3. Global Albendazole by: Distribution Channel (Value)
        • 7.2.3.1. Hospital Pharmacy
        • 7.2.3.2. Retail Pharmacy
        • 7.2.3.3. Online
        • 7.2.3.4. Others
      • 7.2.4. Global Albendazole by: End User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Clinics
        • 7.2.4.3. Others
      • 7.2.5. Global Albendazole Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Albendazole (Volume)
      • 7.3.1. Global Albendazole by: Type (Volume)
        • 7.3.1.1. Capsule
        • 7.3.1.2. Tablet
      • 7.3.2. Global Albendazole by: Application (Volume)
        • 7.3.2.1. Flatworms
        • 7.3.2.2. Nematodes
        • 7.3.2.3. Giardiasis
        • 7.3.2.4. Microsporidiosis
        • 7.3.2.5. Granulomatous Amoebic Encephalitis
        • 7.3.2.6. Arthropods
        • 7.3.2.7. Others
      • 7.3.3. Global Albendazole by: Distribution Channel (Volume)
        • 7.3.3.1. Hospital Pharmacy
        • 7.3.3.2. Retail Pharmacy
        • 7.3.3.3. Online
        • 7.3.3.4. Others
      • 7.3.4. Global Albendazole by: End User (Volume)
        • 7.3.4.1. Hospitals
        • 7.3.4.2. Clinics
        • 7.3.4.3. Others
      • 7.3.5. Global Albendazole Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Albendazole (Price)
      • 7.4.1. Global Albendazole by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Albendazole: by Type(USD Million)
  • Table 2. Albendazole Capsule , by Region USD Million (2016-2021)
  • Table 3. Albendazole Tablet , by Region USD Million (2016-2021)
  • Table 4. Albendazole: by Application(USD Million)
  • Table 5. Albendazole Flatworms , by Region USD Million (2016-2021)
  • Table 6. Albendazole Nematodes , by Region USD Million (2016-2021)
  • Table 7. Albendazole Giardiasis , by Region USD Million (2016-2021)
  • Table 8. Albendazole Microsporidiosis , by Region USD Million (2016-2021)
  • Table 9. Albendazole Granulomatous Amoebic Encephalitis , by Region USD Million (2016-2021)
  • Table 10. Albendazole Arthropods , by Region USD Million (2016-2021)
  • Table 11. Albendazole Others , by Region USD Million (2016-2021)
  • Table 12. Albendazole: by Distribution Channel(USD Million)
  • Table 13. Albendazole Hospital Pharmacy , by Region USD Million (2016-2021)
  • Table 14. Albendazole Retail Pharmacy , by Region USD Million (2016-2021)
  • Table 15. Albendazole Online , by Region USD Million (2016-2021)
  • Table 16. Albendazole Others , by Region USD Million (2016-2021)
  • Table 17. Albendazole: by End User(USD Million)
  • Table 18. Albendazole Hospitals , by Region USD Million (2016-2021)
  • Table 19. Albendazole Clinics , by Region USD Million (2016-2021)
  • Table 20. Albendazole Others , by Region USD Million (2016-2021)
  • Table 21. South America Albendazole, by Country USD Million (2016-2021)
  • Table 22. South America Albendazole, by Type USD Million (2016-2021)
  • Table 23. South America Albendazole, by Application USD Million (2016-2021)
  • Table 24. South America Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 25. South America Albendazole, by End User USD Million (2016-2021)
  • Table 26. Brazil Albendazole, by Type USD Million (2016-2021)
  • Table 27. Brazil Albendazole, by Application USD Million (2016-2021)
  • Table 28. Brazil Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 29. Brazil Albendazole, by End User USD Million (2016-2021)
  • Table 30. Argentina Albendazole, by Type USD Million (2016-2021)
  • Table 31. Argentina Albendazole, by Application USD Million (2016-2021)
  • Table 32. Argentina Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 33. Argentina Albendazole, by End User USD Million (2016-2021)
  • Table 34. Rest of South America Albendazole, by Type USD Million (2016-2021)
  • Table 35. Rest of South America Albendazole, by Application USD Million (2016-2021)
  • Table 36. Rest of South America Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 37. Rest of South America Albendazole, by End User USD Million (2016-2021)
  • Table 38. Asia Pacific Albendazole, by Country USD Million (2016-2021)
  • Table 39. Asia Pacific Albendazole, by Type USD Million (2016-2021)
  • Table 40. Asia Pacific Albendazole, by Application USD Million (2016-2021)
  • Table 41. Asia Pacific Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 42. Asia Pacific Albendazole, by End User USD Million (2016-2021)
  • Table 43. China Albendazole, by Type USD Million (2016-2021)
  • Table 44. China Albendazole, by Application USD Million (2016-2021)
  • Table 45. China Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 46. China Albendazole, by End User USD Million (2016-2021)
  • Table 47. Japan Albendazole, by Type USD Million (2016-2021)
  • Table 48. Japan Albendazole, by Application USD Million (2016-2021)
  • Table 49. Japan Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 50. Japan Albendazole, by End User USD Million (2016-2021)
  • Table 51. India Albendazole, by Type USD Million (2016-2021)
  • Table 52. India Albendazole, by Application USD Million (2016-2021)
  • Table 53. India Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 54. India Albendazole, by End User USD Million (2016-2021)
  • Table 55. South Korea Albendazole, by Type USD Million (2016-2021)
  • Table 56. South Korea Albendazole, by Application USD Million (2016-2021)
  • Table 57. South Korea Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 58. South Korea Albendazole, by End User USD Million (2016-2021)
  • Table 59. Taiwan Albendazole, by Type USD Million (2016-2021)
  • Table 60. Taiwan Albendazole, by Application USD Million (2016-2021)
  • Table 61. Taiwan Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 62. Taiwan Albendazole, by End User USD Million (2016-2021)
  • Table 63. Australia Albendazole, by Type USD Million (2016-2021)
  • Table 64. Australia Albendazole, by Application USD Million (2016-2021)
  • Table 65. Australia Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 66. Australia Albendazole, by End User USD Million (2016-2021)
  • Table 67. Rest of Asia-Pacific Albendazole, by Type USD Million (2016-2021)
  • Table 68. Rest of Asia-Pacific Albendazole, by Application USD Million (2016-2021)
  • Table 69. Rest of Asia-Pacific Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 70. Rest of Asia-Pacific Albendazole, by End User USD Million (2016-2021)
  • Table 71. Europe Albendazole, by Country USD Million (2016-2021)
  • Table 72. Europe Albendazole, by Type USD Million (2016-2021)
  • Table 73. Europe Albendazole, by Application USD Million (2016-2021)
  • Table 74. Europe Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 75. Europe Albendazole, by End User USD Million (2016-2021)
  • Table 76. Germany Albendazole, by Type USD Million (2016-2021)
  • Table 77. Germany Albendazole, by Application USD Million (2016-2021)
  • Table 78. Germany Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 79. Germany Albendazole, by End User USD Million (2016-2021)
  • Table 80. France Albendazole, by Type USD Million (2016-2021)
  • Table 81. France Albendazole, by Application USD Million (2016-2021)
  • Table 82. France Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 83. France Albendazole, by End User USD Million (2016-2021)
  • Table 84. Italy Albendazole, by Type USD Million (2016-2021)
  • Table 85. Italy Albendazole, by Application USD Million (2016-2021)
  • Table 86. Italy Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 87. Italy Albendazole, by End User USD Million (2016-2021)
  • Table 88. United Kingdom Albendazole, by Type USD Million (2016-2021)
  • Table 89. United Kingdom Albendazole, by Application USD Million (2016-2021)
  • Table 90. United Kingdom Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 91. United Kingdom Albendazole, by End User USD Million (2016-2021)
  • Table 92. Netherlands Albendazole, by Type USD Million (2016-2021)
  • Table 93. Netherlands Albendazole, by Application USD Million (2016-2021)
  • Table 94. Netherlands Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 95. Netherlands Albendazole, by End User USD Million (2016-2021)
  • Table 96. Rest of Europe Albendazole, by Type USD Million (2016-2021)
  • Table 97. Rest of Europe Albendazole, by Application USD Million (2016-2021)
  • Table 98. Rest of Europe Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 99. Rest of Europe Albendazole, by End User USD Million (2016-2021)
  • Table 100. MEA Albendazole, by Country USD Million (2016-2021)
  • Table 101. MEA Albendazole, by Type USD Million (2016-2021)
  • Table 102. MEA Albendazole, by Application USD Million (2016-2021)
  • Table 103. MEA Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 104. MEA Albendazole, by End User USD Million (2016-2021)
  • Table 105. Middle East Albendazole, by Type USD Million (2016-2021)
  • Table 106. Middle East Albendazole, by Application USD Million (2016-2021)
  • Table 107. Middle East Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 108. Middle East Albendazole, by End User USD Million (2016-2021)
  • Table 109. Africa Albendazole, by Type USD Million (2016-2021)
  • Table 110. Africa Albendazole, by Application USD Million (2016-2021)
  • Table 111. Africa Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 112. Africa Albendazole, by End User USD Million (2016-2021)
  • Table 113. North America Albendazole, by Country USD Million (2016-2021)
  • Table 114. North America Albendazole, by Type USD Million (2016-2021)
  • Table 115. North America Albendazole, by Application USD Million (2016-2021)
  • Table 116. North America Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 117. North America Albendazole, by End User USD Million (2016-2021)
  • Table 118. United States Albendazole, by Type USD Million (2016-2021)
  • Table 119. United States Albendazole, by Application USD Million (2016-2021)
  • Table 120. United States Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 121. United States Albendazole, by End User USD Million (2016-2021)
  • Table 122. Canada Albendazole, by Type USD Million (2016-2021)
  • Table 123. Canada Albendazole, by Application USD Million (2016-2021)
  • Table 124. Canada Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 125. Canada Albendazole, by End User USD Million (2016-2021)
  • Table 126. Mexico Albendazole, by Type USD Million (2016-2021)
  • Table 127. Mexico Albendazole, by Application USD Million (2016-2021)
  • Table 128. Mexico Albendazole, by Distribution Channel USD Million (2016-2021)
  • Table 129. Mexico Albendazole, by End User USD Million (2016-2021)
  • Table 130. Albendazole Sales: by Type(Tonne)
  • Table 131. Albendazole Sales Capsule , by Region Tonne (2016-2021)
  • Table 132. Albendazole Sales Tablet , by Region Tonne (2016-2021)
  • Table 133. Albendazole Sales: by Application(Tonne)
  • Table 134. Albendazole Sales Flatworms , by Region Tonne (2016-2021)
  • Table 135. Albendazole Sales Nematodes , by Region Tonne (2016-2021)
  • Table 136. Albendazole Sales Giardiasis , by Region Tonne (2016-2021)
  • Table 137. Albendazole Sales Microsporidiosis , by Region Tonne (2016-2021)
  • Table 138. Albendazole Sales Granulomatous Amoebic Encephalitis , by Region Tonne (2016-2021)
  • Table 139. Albendazole Sales Arthropods , by Region Tonne (2016-2021)
  • Table 140. Albendazole Sales Others , by Region Tonne (2016-2021)
  • Table 141. Albendazole Sales: by Distribution Channel(Tonne)
  • Table 142. Albendazole Sales Hospital Pharmacy , by Region Tonne (2016-2021)
  • Table 143. Albendazole Sales Retail Pharmacy , by Region Tonne (2016-2021)
  • Table 144. Albendazole Sales Online , by Region Tonne (2016-2021)
  • Table 145. Albendazole Sales Others , by Region Tonne (2016-2021)
  • Table 146. Albendazole Sales: by End User(Tonne)
  • Table 147. Albendazole Sales Hospitals , by Region Tonne (2016-2021)
  • Table 148. Albendazole Sales Clinics , by Region Tonne (2016-2021)
  • Table 149. Albendazole Sales Others , by Region Tonne (2016-2021)
  • Table 150. South America Albendazole Sales, by Country Tonne (2016-2021)
  • Table 151. South America Albendazole Sales, by Type Tonne (2016-2021)
  • Table 152. South America Albendazole Sales, by Application Tonne (2016-2021)
  • Table 153. South America Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 154. South America Albendazole Sales, by End User Tonne (2016-2021)
  • Table 155. Brazil Albendazole Sales, by Type Tonne (2016-2021)
  • Table 156. Brazil Albendazole Sales, by Application Tonne (2016-2021)
  • Table 157. Brazil Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 158. Brazil Albendazole Sales, by End User Tonne (2016-2021)
  • Table 159. Argentina Albendazole Sales, by Type Tonne (2016-2021)
  • Table 160. Argentina Albendazole Sales, by Application Tonne (2016-2021)
  • Table 161. Argentina Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 162. Argentina Albendazole Sales, by End User Tonne (2016-2021)
  • Table 163. Rest of South America Albendazole Sales, by Type Tonne (2016-2021)
  • Table 164. Rest of South America Albendazole Sales, by Application Tonne (2016-2021)
  • Table 165. Rest of South America Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 166. Rest of South America Albendazole Sales, by End User Tonne (2016-2021)
  • Table 167. Asia Pacific Albendazole Sales, by Country Tonne (2016-2021)
  • Table 168. Asia Pacific Albendazole Sales, by Type Tonne (2016-2021)
  • Table 169. Asia Pacific Albendazole Sales, by Application Tonne (2016-2021)
  • Table 170. Asia Pacific Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 171. Asia Pacific Albendazole Sales, by End User Tonne (2016-2021)
  • Table 172. China Albendazole Sales, by Type Tonne (2016-2021)
  • Table 173. China Albendazole Sales, by Application Tonne (2016-2021)
  • Table 174. China Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 175. China Albendazole Sales, by End User Tonne (2016-2021)
  • Table 176. Japan Albendazole Sales, by Type Tonne (2016-2021)
  • Table 177. Japan Albendazole Sales, by Application Tonne (2016-2021)
  • Table 178. Japan Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 179. Japan Albendazole Sales, by End User Tonne (2016-2021)
  • Table 180. India Albendazole Sales, by Type Tonne (2016-2021)
  • Table 181. India Albendazole Sales, by Application Tonne (2016-2021)
  • Table 182. India Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 183. India Albendazole Sales, by End User Tonne (2016-2021)
  • Table 184. South Korea Albendazole Sales, by Type Tonne (2016-2021)
  • Table 185. South Korea Albendazole Sales, by Application Tonne (2016-2021)
  • Table 186. South Korea Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 187. South Korea Albendazole Sales, by End User Tonne (2016-2021)
  • Table 188. Taiwan Albendazole Sales, by Type Tonne (2016-2021)
  • Table 189. Taiwan Albendazole Sales, by Application Tonne (2016-2021)
  • Table 190. Taiwan Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 191. Taiwan Albendazole Sales, by End User Tonne (2016-2021)
  • Table 192. Australia Albendazole Sales, by Type Tonne (2016-2021)
  • Table 193. Australia Albendazole Sales, by Application Tonne (2016-2021)
  • Table 194. Australia Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 195. Australia Albendazole Sales, by End User Tonne (2016-2021)
  • Table 196. Rest of Asia-Pacific Albendazole Sales, by Type Tonne (2016-2021)
  • Table 197. Rest of Asia-Pacific Albendazole Sales, by Application Tonne (2016-2021)
  • Table 198. Rest of Asia-Pacific Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 199. Rest of Asia-Pacific Albendazole Sales, by End User Tonne (2016-2021)
  • Table 200. Europe Albendazole Sales, by Country Tonne (2016-2021)
  • Table 201. Europe Albendazole Sales, by Type Tonne (2016-2021)
  • Table 202. Europe Albendazole Sales, by Application Tonne (2016-2021)
  • Table 203. Europe Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 204. Europe Albendazole Sales, by End User Tonne (2016-2021)
  • Table 205. Germany Albendazole Sales, by Type Tonne (2016-2021)
  • Table 206. Germany Albendazole Sales, by Application Tonne (2016-2021)
  • Table 207. Germany Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 208. Germany Albendazole Sales, by End User Tonne (2016-2021)
  • Table 209. France Albendazole Sales, by Type Tonne (2016-2021)
  • Table 210. France Albendazole Sales, by Application Tonne (2016-2021)
  • Table 211. France Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 212. France Albendazole Sales, by End User Tonne (2016-2021)
  • Table 213. Italy Albendazole Sales, by Type Tonne (2016-2021)
  • Table 214. Italy Albendazole Sales, by Application Tonne (2016-2021)
  • Table 215. Italy Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 216. Italy Albendazole Sales, by End User Tonne (2016-2021)
  • Table 217. United Kingdom Albendazole Sales, by Type Tonne (2016-2021)
  • Table 218. United Kingdom Albendazole Sales, by Application Tonne (2016-2021)
  • Table 219. United Kingdom Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 220. United Kingdom Albendazole Sales, by End User Tonne (2016-2021)
  • Table 221. Netherlands Albendazole Sales, by Type Tonne (2016-2021)
  • Table 222. Netherlands Albendazole Sales, by Application Tonne (2016-2021)
  • Table 223. Netherlands Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 224. Netherlands Albendazole Sales, by End User Tonne (2016-2021)
  • Table 225. Rest of Europe Albendazole Sales, by Type Tonne (2016-2021)
  • Table 226. Rest of Europe Albendazole Sales, by Application Tonne (2016-2021)
  • Table 227. Rest of Europe Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 228. Rest of Europe Albendazole Sales, by End User Tonne (2016-2021)
  • Table 229. MEA Albendazole Sales, by Country Tonne (2016-2021)
  • Table 230. MEA Albendazole Sales, by Type Tonne (2016-2021)
  • Table 231. MEA Albendazole Sales, by Application Tonne (2016-2021)
  • Table 232. MEA Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 233. MEA Albendazole Sales, by End User Tonne (2016-2021)
  • Table 234. Middle East Albendazole Sales, by Type Tonne (2016-2021)
  • Table 235. Middle East Albendazole Sales, by Application Tonne (2016-2021)
  • Table 236. Middle East Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 237. Middle East Albendazole Sales, by End User Tonne (2016-2021)
  • Table 238. Africa Albendazole Sales, by Type Tonne (2016-2021)
  • Table 239. Africa Albendazole Sales, by Application Tonne (2016-2021)
  • Table 240. Africa Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 241. Africa Albendazole Sales, by End User Tonne (2016-2021)
  • Table 242. North America Albendazole Sales, by Country Tonne (2016-2021)
  • Table 243. North America Albendazole Sales, by Type Tonne (2016-2021)
  • Table 244. North America Albendazole Sales, by Application Tonne (2016-2021)
  • Table 245. North America Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 246. North America Albendazole Sales, by End User Tonne (2016-2021)
  • Table 247. United States Albendazole Sales, by Type Tonne (2016-2021)
  • Table 248. United States Albendazole Sales, by Application Tonne (2016-2021)
  • Table 249. United States Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 250. United States Albendazole Sales, by End User Tonne (2016-2021)
  • Table 251. Canada Albendazole Sales, by Type Tonne (2016-2021)
  • Table 252. Canada Albendazole Sales, by Application Tonne (2016-2021)
  • Table 253. Canada Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 254. Canada Albendazole Sales, by End User Tonne (2016-2021)
  • Table 255. Mexico Albendazole Sales, by Type Tonne (2016-2021)
  • Table 256. Mexico Albendazole Sales, by Application Tonne (2016-2021)
  • Table 257. Mexico Albendazole Sales, by Distribution Channel Tonne (2016-2021)
  • Table 258. Mexico Albendazole Sales, by End User Tonne (2016-2021)
  • Table 259. Albendazole: by Type(USD/Units)
  • Table 260. Company Basic Information, Sales Area and Its Competitors
  • Table 261. Company Basic Information, Sales Area and Its Competitors
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Company Basic Information, Sales Area and Its Competitors
  • Table 271. Albendazole: by Type(USD Million)
  • Table 272. Albendazole Capsule , by Region USD Million (2022-2027)
  • Table 273. Albendazole Tablet , by Region USD Million (2022-2027)
  • Table 274. Albendazole: by Application(USD Million)
  • Table 275. Albendazole Flatworms , by Region USD Million (2022-2027)
  • Table 276. Albendazole Nematodes , by Region USD Million (2022-2027)
  • Table 277. Albendazole Giardiasis , by Region USD Million (2022-2027)
  • Table 278. Albendazole Microsporidiosis , by Region USD Million (2022-2027)
  • Table 279. Albendazole Granulomatous Amoebic Encephalitis , by Region USD Million (2022-2027)
  • Table 280. Albendazole Arthropods , by Region USD Million (2022-2027)
  • Table 281. Albendazole Others , by Region USD Million (2022-2027)
  • Table 282. Albendazole: by Distribution Channel(USD Million)
  • Table 283. Albendazole Hospital Pharmacy , by Region USD Million (2022-2027)
  • Table 284. Albendazole Retail Pharmacy , by Region USD Million (2022-2027)
  • Table 285. Albendazole Online , by Region USD Million (2022-2027)
  • Table 286. Albendazole Others , by Region USD Million (2022-2027)
  • Table 287. Albendazole: by End User(USD Million)
  • Table 288. Albendazole Hospitals , by Region USD Million (2022-2027)
  • Table 289. Albendazole Clinics , by Region USD Million (2022-2027)
  • Table 290. Albendazole Others , by Region USD Million (2022-2027)
  • Table 291. South America Albendazole, by Country USD Million (2022-2027)
  • Table 292. South America Albendazole, by Type USD Million (2022-2027)
  • Table 293. South America Albendazole, by Application USD Million (2022-2027)
  • Table 294. South America Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 295. South America Albendazole, by End User USD Million (2022-2027)
  • Table 296. Brazil Albendazole, by Type USD Million (2022-2027)
  • Table 297. Brazil Albendazole, by Application USD Million (2022-2027)
  • Table 298. Brazil Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 299. Brazil Albendazole, by End User USD Million (2022-2027)
  • Table 300. Argentina Albendazole, by Type USD Million (2022-2027)
  • Table 301. Argentina Albendazole, by Application USD Million (2022-2027)
  • Table 302. Argentina Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 303. Argentina Albendazole, by End User USD Million (2022-2027)
  • Table 304. Rest of South America Albendazole, by Type USD Million (2022-2027)
  • Table 305. Rest of South America Albendazole, by Application USD Million (2022-2027)
  • Table 306. Rest of South America Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 307. Rest of South America Albendazole, by End User USD Million (2022-2027)
  • Table 308. Asia Pacific Albendazole, by Country USD Million (2022-2027)
  • Table 309. Asia Pacific Albendazole, by Type USD Million (2022-2027)
  • Table 310. Asia Pacific Albendazole, by Application USD Million (2022-2027)
  • Table 311. Asia Pacific Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 312. Asia Pacific Albendazole, by End User USD Million (2022-2027)
  • Table 313. China Albendazole, by Type USD Million (2022-2027)
  • Table 314. China Albendazole, by Application USD Million (2022-2027)
  • Table 315. China Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 316. China Albendazole, by End User USD Million (2022-2027)
  • Table 317. Japan Albendazole, by Type USD Million (2022-2027)
  • Table 318. Japan Albendazole, by Application USD Million (2022-2027)
  • Table 319. Japan Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 320. Japan Albendazole, by End User USD Million (2022-2027)
  • Table 321. India Albendazole, by Type USD Million (2022-2027)
  • Table 322. India Albendazole, by Application USD Million (2022-2027)
  • Table 323. India Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 324. India Albendazole, by End User USD Million (2022-2027)
  • Table 325. South Korea Albendazole, by Type USD Million (2022-2027)
  • Table 326. South Korea Albendazole, by Application USD Million (2022-2027)
  • Table 327. South Korea Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 328. South Korea Albendazole, by End User USD Million (2022-2027)
  • Table 329. Taiwan Albendazole, by Type USD Million (2022-2027)
  • Table 330. Taiwan Albendazole, by Application USD Million (2022-2027)
  • Table 331. Taiwan Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 332. Taiwan Albendazole, by End User USD Million (2022-2027)
  • Table 333. Australia Albendazole, by Type USD Million (2022-2027)
  • Table 334. Australia Albendazole, by Application USD Million (2022-2027)
  • Table 335. Australia Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 336. Australia Albendazole, by End User USD Million (2022-2027)
  • Table 337. Rest of Asia-Pacific Albendazole, by Type USD Million (2022-2027)
  • Table 338. Rest of Asia-Pacific Albendazole, by Application USD Million (2022-2027)
  • Table 339. Rest of Asia-Pacific Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 340. Rest of Asia-Pacific Albendazole, by End User USD Million (2022-2027)
  • Table 341. Europe Albendazole, by Country USD Million (2022-2027)
  • Table 342. Europe Albendazole, by Type USD Million (2022-2027)
  • Table 343. Europe Albendazole, by Application USD Million (2022-2027)
  • Table 344. Europe Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 345. Europe Albendazole, by End User USD Million (2022-2027)
  • Table 346. Germany Albendazole, by Type USD Million (2022-2027)
  • Table 347. Germany Albendazole, by Application USD Million (2022-2027)
  • Table 348. Germany Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 349. Germany Albendazole, by End User USD Million (2022-2027)
  • Table 350. France Albendazole, by Type USD Million (2022-2027)
  • Table 351. France Albendazole, by Application USD Million (2022-2027)
  • Table 352. France Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 353. France Albendazole, by End User USD Million (2022-2027)
  • Table 354. Italy Albendazole, by Type USD Million (2022-2027)
  • Table 355. Italy Albendazole, by Application USD Million (2022-2027)
  • Table 356. Italy Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 357. Italy Albendazole, by End User USD Million (2022-2027)
  • Table 358. United Kingdom Albendazole, by Type USD Million (2022-2027)
  • Table 359. United Kingdom Albendazole, by Application USD Million (2022-2027)
  • Table 360. United Kingdom Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 361. United Kingdom Albendazole, by End User USD Million (2022-2027)
  • Table 362. Netherlands Albendazole, by Type USD Million (2022-2027)
  • Table 363. Netherlands Albendazole, by Application USD Million (2022-2027)
  • Table 364. Netherlands Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 365. Netherlands Albendazole, by End User USD Million (2022-2027)
  • Table 366. Rest of Europe Albendazole, by Type USD Million (2022-2027)
  • Table 367. Rest of Europe Albendazole, by Application USD Million (2022-2027)
  • Table 368. Rest of Europe Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 369. Rest of Europe Albendazole, by End User USD Million (2022-2027)
  • Table 370. MEA Albendazole, by Country USD Million (2022-2027)
  • Table 371. MEA Albendazole, by Type USD Million (2022-2027)
  • Table 372. MEA Albendazole, by Application USD Million (2022-2027)
  • Table 373. MEA Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 374. MEA Albendazole, by End User USD Million (2022-2027)
  • Table 375. Middle East Albendazole, by Type USD Million (2022-2027)
  • Table 376. Middle East Albendazole, by Application USD Million (2022-2027)
  • Table 377. Middle East Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 378. Middle East Albendazole, by End User USD Million (2022-2027)
  • Table 379. Africa Albendazole, by Type USD Million (2022-2027)
  • Table 380. Africa Albendazole, by Application USD Million (2022-2027)
  • Table 381. Africa Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 382. Africa Albendazole, by End User USD Million (2022-2027)
  • Table 383. North America Albendazole, by Country USD Million (2022-2027)
  • Table 384. North America Albendazole, by Type USD Million (2022-2027)
  • Table 385. North America Albendazole, by Application USD Million (2022-2027)
  • Table 386. North America Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 387. North America Albendazole, by End User USD Million (2022-2027)
  • Table 388. United States Albendazole, by Type USD Million (2022-2027)
  • Table 389. United States Albendazole, by Application USD Million (2022-2027)
  • Table 390. United States Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 391. United States Albendazole, by End User USD Million (2022-2027)
  • Table 392. Canada Albendazole, by Type USD Million (2022-2027)
  • Table 393. Canada Albendazole, by Application USD Million (2022-2027)
  • Table 394. Canada Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 395. Canada Albendazole, by End User USD Million (2022-2027)
  • Table 396. Mexico Albendazole, by Type USD Million (2022-2027)
  • Table 397. Mexico Albendazole, by Application USD Million (2022-2027)
  • Table 398. Mexico Albendazole, by Distribution Channel USD Million (2022-2027)
  • Table 399. Mexico Albendazole, by End User USD Million (2022-2027)
  • Table 400. Albendazole Sales: by Type(Tonne)
  • Table 401. Albendazole Sales Capsule , by Region Tonne (2022-2027)
  • Table 402. Albendazole Sales Tablet , by Region Tonne (2022-2027)
  • Table 403. Albendazole Sales: by Application(Tonne)
  • Table 404. Albendazole Sales Flatworms , by Region Tonne (2022-2027)
  • Table 405. Albendazole Sales Nematodes , by Region Tonne (2022-2027)
  • Table 406. Albendazole Sales Giardiasis , by Region Tonne (2022-2027)
  • Table 407. Albendazole Sales Microsporidiosis , by Region Tonne (2022-2027)
  • Table 408. Albendazole Sales Granulomatous Amoebic Encephalitis , by Region Tonne (2022-2027)
  • Table 409. Albendazole Sales Arthropods , by Region Tonne (2022-2027)
  • Table 410. Albendazole Sales Others , by Region Tonne (2022-2027)
  • Table 411. Albendazole Sales: by Distribution Channel(Tonne)
  • Table 412. Albendazole Sales Hospital Pharmacy , by Region Tonne (2022-2027)
  • Table 413. Albendazole Sales Retail Pharmacy , by Region Tonne (2022-2027)
  • Table 414. Albendazole Sales Online , by Region Tonne (2022-2027)
  • Table 415. Albendazole Sales Others , by Region Tonne (2022-2027)
  • Table 416. Albendazole Sales: by End User(Tonne)
  • Table 417. Albendazole Sales Hospitals , by Region Tonne (2022-2027)
  • Table 418. Albendazole Sales Clinics , by Region Tonne (2022-2027)
  • Table 419. Albendazole Sales Others , by Region Tonne (2022-2027)
  • Table 420. South America Albendazole Sales, by Country Tonne (2022-2027)
  • Table 421. South America Albendazole Sales, by Type Tonne (2022-2027)
  • Table 422. South America Albendazole Sales, by Application Tonne (2022-2027)
  • Table 423. South America Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 424. South America Albendazole Sales, by End User Tonne (2022-2027)
  • Table 425. Brazil Albendazole Sales, by Type Tonne (2022-2027)
  • Table 426. Brazil Albendazole Sales, by Application Tonne (2022-2027)
  • Table 427. Brazil Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 428. Brazil Albendazole Sales, by End User Tonne (2022-2027)
  • Table 429. Argentina Albendazole Sales, by Type Tonne (2022-2027)
  • Table 430. Argentina Albendazole Sales, by Application Tonne (2022-2027)
  • Table 431. Argentina Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 432. Argentina Albendazole Sales, by End User Tonne (2022-2027)
  • Table 433. Rest of South America Albendazole Sales, by Type Tonne (2022-2027)
  • Table 434. Rest of South America Albendazole Sales, by Application Tonne (2022-2027)
  • Table 435. Rest of South America Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 436. Rest of South America Albendazole Sales, by End User Tonne (2022-2027)
  • Table 437. Asia Pacific Albendazole Sales, by Country Tonne (2022-2027)
  • Table 438. Asia Pacific Albendazole Sales, by Type Tonne (2022-2027)
  • Table 439. Asia Pacific Albendazole Sales, by Application Tonne (2022-2027)
  • Table 440. Asia Pacific Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 441. Asia Pacific Albendazole Sales, by End User Tonne (2022-2027)
  • Table 442. China Albendazole Sales, by Type Tonne (2022-2027)
  • Table 443. China Albendazole Sales, by Application Tonne (2022-2027)
  • Table 444. China Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 445. China Albendazole Sales, by End User Tonne (2022-2027)
  • Table 446. Japan Albendazole Sales, by Type Tonne (2022-2027)
  • Table 447. Japan Albendazole Sales, by Application Tonne (2022-2027)
  • Table 448. Japan Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 449. Japan Albendazole Sales, by End User Tonne (2022-2027)
  • Table 450. India Albendazole Sales, by Type Tonne (2022-2027)
  • Table 451. India Albendazole Sales, by Application Tonne (2022-2027)
  • Table 452. India Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 453. India Albendazole Sales, by End User Tonne (2022-2027)
  • Table 454. South Korea Albendazole Sales, by Type Tonne (2022-2027)
  • Table 455. South Korea Albendazole Sales, by Application Tonne (2022-2027)
  • Table 456. South Korea Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 457. South Korea Albendazole Sales, by End User Tonne (2022-2027)
  • Table 458. Taiwan Albendazole Sales, by Type Tonne (2022-2027)
  • Table 459. Taiwan Albendazole Sales, by Application Tonne (2022-2027)
  • Table 460. Taiwan Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 461. Taiwan Albendazole Sales, by End User Tonne (2022-2027)
  • Table 462. Australia Albendazole Sales, by Type Tonne (2022-2027)
  • Table 463. Australia Albendazole Sales, by Application Tonne (2022-2027)
  • Table 464. Australia Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 465. Australia Albendazole Sales, by End User Tonne (2022-2027)
  • Table 466. Rest of Asia-Pacific Albendazole Sales, by Type Tonne (2022-2027)
  • Table 467. Rest of Asia-Pacific Albendazole Sales, by Application Tonne (2022-2027)
  • Table 468. Rest of Asia-Pacific Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 469. Rest of Asia-Pacific Albendazole Sales, by End User Tonne (2022-2027)
  • Table 470. Europe Albendazole Sales, by Country Tonne (2022-2027)
  • Table 471. Europe Albendazole Sales, by Type Tonne (2022-2027)
  • Table 472. Europe Albendazole Sales, by Application Tonne (2022-2027)
  • Table 473. Europe Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 474. Europe Albendazole Sales, by End User Tonne (2022-2027)
  • Table 475. Germany Albendazole Sales, by Type Tonne (2022-2027)
  • Table 476. Germany Albendazole Sales, by Application Tonne (2022-2027)
  • Table 477. Germany Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 478. Germany Albendazole Sales, by End User Tonne (2022-2027)
  • Table 479. France Albendazole Sales, by Type Tonne (2022-2027)
  • Table 480. France Albendazole Sales, by Application Tonne (2022-2027)
  • Table 481. France Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 482. France Albendazole Sales, by End User Tonne (2022-2027)
  • Table 483. Italy Albendazole Sales, by Type Tonne (2022-2027)
  • Table 484. Italy Albendazole Sales, by Application Tonne (2022-2027)
  • Table 485. Italy Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 486. Italy Albendazole Sales, by End User Tonne (2022-2027)
  • Table 487. United Kingdom Albendazole Sales, by Type Tonne (2022-2027)
  • Table 488. United Kingdom Albendazole Sales, by Application Tonne (2022-2027)
  • Table 489. United Kingdom Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 490. United Kingdom Albendazole Sales, by End User Tonne (2022-2027)
  • Table 491. Netherlands Albendazole Sales, by Type Tonne (2022-2027)
  • Table 492. Netherlands Albendazole Sales, by Application Tonne (2022-2027)
  • Table 493. Netherlands Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 494. Netherlands Albendazole Sales, by End User Tonne (2022-2027)
  • Table 495. Rest of Europe Albendazole Sales, by Type Tonne (2022-2027)
  • Table 496. Rest of Europe Albendazole Sales, by Application Tonne (2022-2027)
  • Table 497. Rest of Europe Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 498. Rest of Europe Albendazole Sales, by End User Tonne (2022-2027)
  • Table 499. MEA Albendazole Sales, by Country Tonne (2022-2027)
  • Table 500. MEA Albendazole Sales, by Type Tonne (2022-2027)
  • Table 501. MEA Albendazole Sales, by Application Tonne (2022-2027)
  • Table 502. MEA Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 503. MEA Albendazole Sales, by End User Tonne (2022-2027)
  • Table 504. Middle East Albendazole Sales, by Type Tonne (2022-2027)
  • Table 505. Middle East Albendazole Sales, by Application Tonne (2022-2027)
  • Table 506. Middle East Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 507. Middle East Albendazole Sales, by End User Tonne (2022-2027)
  • Table 508. Africa Albendazole Sales, by Type Tonne (2022-2027)
  • Table 509. Africa Albendazole Sales, by Application Tonne (2022-2027)
  • Table 510. Africa Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 511. Africa Albendazole Sales, by End User Tonne (2022-2027)
  • Table 512. North America Albendazole Sales, by Country Tonne (2022-2027)
  • Table 513. North America Albendazole Sales, by Type Tonne (2022-2027)
  • Table 514. North America Albendazole Sales, by Application Tonne (2022-2027)
  • Table 515. North America Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 516. North America Albendazole Sales, by End User Tonne (2022-2027)
  • Table 517. United States Albendazole Sales, by Type Tonne (2022-2027)
  • Table 518. United States Albendazole Sales, by Application Tonne (2022-2027)
  • Table 519. United States Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 520. United States Albendazole Sales, by End User Tonne (2022-2027)
  • Table 521. Canada Albendazole Sales, by Type Tonne (2022-2027)
  • Table 522. Canada Albendazole Sales, by Application Tonne (2022-2027)
  • Table 523. Canada Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 524. Canada Albendazole Sales, by End User Tonne (2022-2027)
  • Table 525. Mexico Albendazole Sales, by Type Tonne (2022-2027)
  • Table 526. Mexico Albendazole Sales, by Application Tonne (2022-2027)
  • Table 527. Mexico Albendazole Sales, by Distribution Channel Tonne (2022-2027)
  • Table 528. Mexico Albendazole Sales, by End User Tonne (2022-2027)
  • Table 529. Albendazole: by Type(USD/Units)
  • Table 530. Research Programs/Design for This Report
  • Table 531. Key Data Information from Secondary Sources
  • Table 532. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Albendazole: by Type USD Million (2016-2021)
  • Figure 5. Global Albendazole: by Application USD Million (2016-2021)
  • Figure 6. Global Albendazole: by Distribution Channel USD Million (2016-2021)
  • Figure 7. Global Albendazole: by End User USD Million (2016-2021)
  • Figure 8. South America Albendazole Share (%), by Country
  • Figure 9. Asia Pacific Albendazole Share (%), by Country
  • Figure 10. Europe Albendazole Share (%), by Country
  • Figure 11. MEA Albendazole Share (%), by Country
  • Figure 12. North America Albendazole Share (%), by Country
  • Figure 13. Global Albendazole: by Type Tonne (2016-2021)
  • Figure 14. Global Albendazole: by Application Tonne (2016-2021)
  • Figure 15. Global Albendazole: by Distribution Channel Tonne (2016-2021)
  • Figure 16. Global Albendazole: by End User Tonne (2016-2021)
  • Figure 17. South America Albendazole Share (%), by Country
  • Figure 18. Asia Pacific Albendazole Share (%), by Country
  • Figure 19. Europe Albendazole Share (%), by Country
  • Figure 20. MEA Albendazole Share (%), by Country
  • Figure 21. North America Albendazole Share (%), by Country
  • Figure 22. Global Albendazole: by Type USD/Units (2016-2021)
  • Figure 23. Global Albendazole share by Players 2021 (%)
  • Figure 24. Global Albendazole share by Players (Top 3) 2021(%)
  • Figure 25. Global Albendazole share by Players (Top 5) 2021(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer (United States) Revenue: by Geography 2021
  • Figure 29. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Bayer AG (Germany) Revenue: by Geography 2021
  • Figure 31. Merck & Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck & Co., Inc. (United States) Revenue: by Geography 2021
  • Figure 33. Provet (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Provet (Switzerland) Revenue: by Geography 2021
  • Figure 35. Virbac (India) Revenue, Net Income and Gross profit
  • Figure 36. Virbac (India) Revenue: by Geography 2021
  • Figure 37. Cipla (India) Revenue, Net Income and Gross profit
  • Figure 38. Cipla (India) Revenue: by Geography 2021
  • Figure 39. Novartis AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. Novartis AG (Switzerland) Revenue: by Geography 2021
  • Figure 41. CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 42. CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India) Revenue: by Geography 2021
  • Figure 43. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2021
  • Figure 45. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 46. Abbott (United States) Revenue: by Geography 2021
  • Figure 47. Arsanis, Inc. (Austria) Revenue, Net Income and Gross profit
  • Figure 48. Arsanis, Inc. (Austria) Revenue: by Geography 2021
  • Figure 49. Global Albendazole: by Type USD Million (2022-2027)
  • Figure 50. Global Albendazole: by Application USD Million (2022-2027)
  • Figure 51. Global Albendazole: by Distribution Channel USD Million (2022-2027)
  • Figure 52. Global Albendazole: by End User USD Million (2022-2027)
  • Figure 53. South America Albendazole Share (%), by Country
  • Figure 54. Asia Pacific Albendazole Share (%), by Country
  • Figure 55. Europe Albendazole Share (%), by Country
  • Figure 56. MEA Albendazole Share (%), by Country
  • Figure 57. North America Albendazole Share (%), by Country
  • Figure 58. Global Albendazole: by Type Tonne (2022-2027)
  • Figure 59. Global Albendazole: by Application Tonne (2022-2027)
  • Figure 60. Global Albendazole: by Distribution Channel Tonne (2022-2027)
  • Figure 61. Global Albendazole: by End User Tonne (2022-2027)
  • Figure 62. South America Albendazole Share (%), by Country
  • Figure 63. Asia Pacific Albendazole Share (%), by Country
  • Figure 64. Europe Albendazole Share (%), by Country
  • Figure 65. MEA Albendazole Share (%), by Country
  • Figure 66. North America Albendazole Share (%), by Country
  • Figure 67. Global Albendazole: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (United States)
  • Provet (Switzerland)
  • Virbac (India)
  • Cipla (India)
  • Novartis AG (Switzerland)
  • CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott (United States)
  • Arsanis, Inc. (Austria)
Additional players considered in the study are as follows:
Novabiotics (United Kingdom) , GlaxoSmithKline plc. (United Kingdom) , Teva Pharmaceutical Industries Ltd (Taiwan) , Lupin Limited (India)
Select User Access Type

Key Highlights of Report


Apr 2022 204 Pages 66 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Albendazole Quantitative research analysis
Global Albendazole Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Increasing Incidence of Clonorchis Infections in Asia Pacific Region " is seen as one of major growth factors of Albendazole Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
European and Asian will lead Albendazole Market in coming years.

Know More About Global Albendazole Report?

Have a Query? Click Here

Other Related Reports

Axillary Hyperhidrosis Drug Comprehensive Study by Type (Prescription Antiperspirant, Nerve-blocking Medications, Antidepressants, Botulinum Toxin Injections, Others), Application (Clinic, Hospital, ...
$ 3750
Heparin Calcium Comprehensive Study by Type (Unfractionated Heparin, Low molecular Heparin API), Application (Heart Attacks and Bypass Surgeries, Kidney Dialysis Processes, Extracorporeal Life Suppo...
$ 3650
Nanostructured Drug Comprehensive Study by Type (Liposomes, Polymeric Micelles, Solid Lipid Nanoparticles, Microemulsion and Nanoemulsion, Nanosuspension), Application (Cardiovascular/Chronic, Immuno...
$ 3650
Vegetable Capsules Comprehensive Study by Type (HPMC with Gelling Agent, HPMC without Gelling Agent, Plant Polysaccarides, Starch, Pullulan), Application (Supplements, Medicine, Cosmetics), End Use...
$ 3450
Angioedema Treatment Comprehensive Study by Type (Antihistamines, Corticosteroids, Others), Application (Hospitals, Clinics, Research Organizations ), Drugs (C1 Esterase Inhibitor, Selective Bradykin...
$ 3450
Sodium Chloride Injection Comprehensive Study by Application (Hospitals, Clinics, Other Medical Institutions), Container (Flexible Bag, Plastic Bottles, Glass Bottles), Distribution Channel (Online, ...
$ 3500